Canine mammary gland cancer (CMGC) is the most common neoplastic condition in bitches and is often fatal. There are limited treatment options for CMGC. Primary cell cultures from mammary tumours are promising preclinical in vitro models in which to study
Petrouškova Patŕicia +6 more
doaj +1 more source
Patients with pancreatic neuroendocrine tumors (pNETs) have limited access to effective targeted agents and invariably succumb to progressive disease. MUC1-C is a druggable oncogenic protein linked to driving pan-cancers. There is no known involvement of
Hiroki Ozawa +14 more
doaj +1 more source
Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry–based de novo sequencing
A widely used anti-MUC1 antibody (139H2) is sequenced by mass spectrometry, revealing the molecular basis of its glycosylation-independent binding to this tumor-associated antigen.
Weiwei Peng +9 more
doaj +1 more source
Summary: Stenotrophomonas maltophilia (Sm), a multidrug-resistant pathogen often isolated from immunocompromised individuals, presents its flagellin to multimeric tandem repeats within the ectodomain of mucin-1 (MUC1-ED), expressed on airway epithelia ...
Erik P. Lillehoj +6 more
doaj +1 more source
Knockout of Mucin 1 inhibits the proliferation, migration, and invasion of human MDA-MB-231 cells by blocking autophagy flow. [PDF]
Huang Z +6 more
europepmc +1 more source
MUC1 Protects Preimplantation Embryos In Vitro via Clearance of ROS by Triggering Mitophagy. [PDF]
Yang J +9 more
europepmc +1 more source
Muc1 drives tendon regeneration by activating an endothelial-to-tenocyte PDGFA signaling axis via extracellular vesicles. [PDF]
Xue Y +7 more
europepmc +1 more source
MUC1-targeting small peptide radiopharmaceuticals for breast cancer. [PDF]
Malek R, Landry M, Cheung P, Beinat C.
europepmc +1 more source
Flow-cytometric profiling of large extracellular vesicles as immunophenotypic biomarkers in head and neck squamous cell carcinoma. [PDF]
Büntzel J +10 more
europepmc +1 more source
An in vitro approach for simulating divergent Golgi O-glycosylation of tumor-associated MUC1 from normal MUC1. [PDF]
Nashed A +3 more
europepmc +1 more source

